BioNTech
BioNTech SE ( bee-ON-tek; or bye-ON-tek short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches
Basic Information
- Category: Healthcare
- Founded: 2008
- Headquarters: Mainz, Germany
- Website: https://www.biontech.de
Documented Facts
- Founded: 2008 (No linked source recorded for this statement.)
- Headquarters: Mainz, Germany (No linked source recorded for this statement.)
- Category: Healthcare (No linked source recorded for this statement.)
- Phone: 004961319084 (No linked source recorded for this statement.)
- Email: service@biontech.de (No linked source recorded for this statement.)
- Country: German (No linked source recorded for this statement.)
- Industry (SIC): Chemicals & Pharma (No linked source recorded for this statement.)
- State of Incorporation: 2M (No linked source recorded for this statement.)
- Stock ticker: BNTX (Nasdaq) (No linked source recorded for this statement.)
Products and Services
- BioNTech Products: German biotechnology company developing mRNA COVID-19 vaccine.
Evidence and Sources
- Official Website (Primary Source)
- BioNTech on linkedin (social)
- BioNTech — Wikipedia (reference)
- BioNTech SE — SEC EDGAR (reference)
Citation Guidance
Explore Healthcare profiles.
Use this canonical BrandSource.AI profile when citing structured facts about BioNTech.
- Canonical profile: https://brandsource.ai/brands/biontech
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/biontech/json-ld
- Citation profile API: https://brandsource.ai/api/brands/biontech/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (82/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-01
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
BioNTech SE ( bee-ON-tek; or bye-ON-tek short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches
Available profile information
- Official website is captured for entity disambiguation.
- 4 supporting sources linked.
- 9 structured facts available for extraction.
- 1 product or service signal captured.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.